| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014370A1 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof |
| 03/01/2001 | WO2001014369A2 Process for the preparation of paroxetin.hcl |
| 03/01/2001 | WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014339A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001014332A1 Piperidine alcohols |
| 03/01/2001 | WO2001014331A2 Non-quinoline inhibitors of malaria parasites |
| 03/01/2001 | WO2001014330A2 Phenylpiperazines as serotonin reuptake inhibitors |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014288A1 Optically active isocyanurate and optical resolver comprising derivative of the same |
| 03/01/2001 | WO2000049019A3 Novel epothilone derivatives, method for producing them and their pharmaceutical use |
| 03/01/2001 | WO2000046203A3 G-protein coupled heptahelical receptor binding compounds and methods of use thereof |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2382295A1 Piperidine alcohols |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2376275A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/28/2001 | EP1078925A1 4-Phenylpiperidine compounds |
| 02/28/2001 | EP1078924A1 Intermediates and a process for producing beta-adrenergic receptor agonists |
| 02/28/2001 | EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient |
| 02/28/2001 | EP1078818A2 Interior rearview mirror sound processing system |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077976A1 Water soluble azoles as broad-spectrum antifungals |
| 02/28/2001 | EP1077975A1 Water soluble azoles as broad-spectrum antifungals |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077973A2 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 02/28/2001 | EP1077972A1 1-alkyl-4-[(3-oxetanyl-)benzoyl]-5-hydroxypyrazole compounds and their use as herbicides |
| 02/28/2001 | EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077947A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077945A1 Isoquinolines as urokinase inhibitors |
| 02/28/2001 | EP1077940A1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 02/28/2001 | EP1077938A1 2-(2-methylphenyl)-3,4-dihydro-2h-pyrrol derivatives |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077920A1 New compounds, their preparation and use |
| 02/28/2001 | EP1077919A1 New compounds, their preparation and use |
| 02/28/2001 | EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 02/28/2001 | EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 02/28/2001 | EP1077685A2 Novel formulation containing paroxetine |
| 02/28/2001 | EP1077682A2 Novel formulation containing paroxetine |
| 02/28/2001 | CN1285829A Method for producing doxazodin mesylate in crystal modification designated as form A and intermediate product for producing the same |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285353A Process for synthesizing doxazosin mesylate |
| 02/28/2001 | CN1062561C 7-halo-and 7beta, 8 beta-methano-taxols, antineoplastic use and pharmaceutical compositions containing them |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2317001A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | US6194585 Process for preparing 5-lipoxygenase inhibitors |
| 02/27/2001 | US6194575 Reacting 2-nitroimino-3,5-dimethyl-1,3, 5-triaza-cyclohexane derivative with urea in presence of diluent to form 1,3-di-substituted 2-nitroguanidine |
| 02/27/2001 | US6194569 Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piperazinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194450 Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/27/2001 | US6194437 Non-peptide bombesin receptor antagonists |
| 02/27/2001 | US6194427 Brain disorders; psychological disorders; sleep disorders; anticonvulsants |
| 02/27/2001 | US6194411 3(2H)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
| 02/27/2001 | US6194409 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/27/2001 | US6194406 Histamine receptor antagonists; tachykinin receptor antagonists; asthma; bronchitis; inflammatory bowel diseases, including crohn's disease and ulcerative colitis; seasonal rhinitis; sinusitis; antiallergens; emetic agents |
| 02/27/2001 | US6194405 3,3a,8,12b-tetrahydro-n-methyl-2h-dibenzo(3,4:6,7)-cyclohepta( 1,2-b)-furan-2-methanamine, for example; anxiolytic agents, antidepressants, sleep and sexual disorders, psychological, cardiovascular and gastrointestinal disorders |
| 02/27/2001 | CA2111204C Piperidine derivatives having anxiolytic effect |
| 02/27/2001 | CA2012267C Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 02/22/2001 | WO2001012624A1 Paroxetine |
| 02/22/2001 | WO2001012623A1 Process for the preparation of paroxetine hydrochloride |
| 02/22/2001 | WO2001012607A2 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 02/22/2001 | WO2001012604A1 Fungicides |
| 02/22/2001 | WO2001012189A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | WO2001012187A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2001011966A1 Fungicides |
| 02/22/2001 | WO2000078724A3 Imidazolinderivatives their preparation and their pharmaceutical use |
| 02/22/2001 | WO2000071538A3 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO2000053597B1 Benzofuran-2-ones as colorants for organic materials |
| 02/22/2001 | WO2000032588A3 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/22/2001 | DE19939756A1 New 1-(1-ethyl-piperidin-4-yl)-1-(phenyl or heterocyclyl)-alkanol derivatives, are 5-HT(2A) receptor antagonists useful e.g. for treating schizophrenia, depression, memory disorders or eating disorders |
| 02/22/2001 | DE19939463A1 Tryptase inhibitors useful e.g. for treating inflammatory or allergic disease, arteriosclerosis or neoplasia, comprising new or known 2-phenethyl-benzimidazole-5-carboxamides |
| 02/22/2001 | DE10025830A1 New 4-acyl-2,3-dihydro-benzofuran or -benzothiophene derivatives, useful as pre- or post-emergence, total or selective herbicides or as plant growth inhibitors |
| 02/22/2001 | CA2381968A1 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2380775A1 Benzoic acid derivatives and their use as ppar receptor agonists |
| 02/21/2001 | EP1076659A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders |
| 02/21/2001 | EP1076655A1 N-pyridonyl herbicides |
| 02/21/2001 | EP1076558A1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens |
| 02/21/2001 | CN1284952A Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 02/21/2001 | CN1284946A Substituted isoquinoline derivatives and their use as anticonvulsants |
| 02/21/2001 | CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use |
| 02/21/2001 | CN1284897A Batch devices for reduction of compounds from biological compositions containing cells and methods of use |
| 02/21/2001 | CN1284896A Flow device for the reduction of compounds from biological compositions and methods of use |
| 02/21/2001 | CN1062270C Amino-acid derrivatives having benzothiophene ring, prep. thereof and use as fungus-killing agent |
| 02/21/2001 | CN1062269C Novel (R)-5-carbamyl-8-fluoro-3-N, N-disubstituted amino-3, 4-dihydro-2H-1-benzopyranes |
| 02/21/2001 | CN1062266C Amidine derivative and platelet agglutination inhibitor containing said amidine derivative |
| 02/21/2001 | CN1062264C Amino-acid indole or quinoline derivatives, prep. thereof and use as fungus-killing agent |
| 02/20/2001 | US6191289 Production process and intermediate of tetrazole compound |
| 02/20/2001 | US6191266 Sugar modified nucleosides |
| 02/20/2001 | US6191134 Stroke therapy, antiischemic agents, brain disorders |
| 02/20/2001 | US6191130 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5T H1A receptors |
| 02/20/2001 | US6190850 Photographic element, compound, and process |
| 02/20/2001 | CA2084036C Use of specific counteranions to modify the solubility of tetrazolium salts |